ICM
FLGT icon

Invenomic Capital Management’s Fulgent Genetics FLGT Stock Holding History

Invenomic Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.7M Buy
+610,318
New +$13.2M 0.45% 67
2025
Q3 		– Sell
-31,125
Closed -$619K – 154
2025
Q2 		$619K Sell
31,125
-205,047
-87% -$4M 0.04% 143
2025
Q1 		$3.99M Sell
236,172
-22,838
-9% -$389K 0.2% 126
2024
Q4 		$4.78M Buy
259,010
+9,263
+4% +$181K 0.23% 112
2024
Q3 		$5.43M Buy
249,747
+124,185
+99% +$2.78M 0.3% 94
2024
Q2 		$2.46M Buy
+125,562
New +$2.62M 0.12% 139

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invenomic Capital Management's FLGT Position: Q1 2026 in Review

Invenomic Capital Management opened a new position in Fulgent Genetics (FLGT) in Q1 2026: 610,318 shares worth $9.7M. The stake represents 0.45% of the portfolio and ranks #67 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in FLGT as recently as Q2 2025.

Invenomic Capital Management first reported a position in FLGT in Q2 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Invenomic Capital Management held 610,318 shares of Fulgent Genetics worth $9.7M as of Q1 2026.
  • Fulgent Genetics was a new Invenomic Capital Management position in Q1 2026.
  • Fulgent Genetics made up 0.45% of Invenomic Capital Management's portfolio in Q1 2026, its #67 holding.
  • Invenomic Capital Management first reported a position in Fulgent Genetics in Q2 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.